AR024013A1 - Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceos - Google Patents
Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceosInfo
- Publication number
- AR024013A1 AR024013A1 ARP000102385A ARP000102385A AR024013A1 AR 024013 A1 AR024013 A1 AR 024013A1 AR P000102385 A ARP000102385 A AR P000102385A AR P000102385 A ARP000102385 A AR P000102385A AR 024013 A1 AR024013 A1 AR 024013A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- treatment
- addition
- active substance
- opiaceans
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
El objeto de la presente consiste en preparados farmacéuticos destinados a ser utilizados en un procedimiento para el tratamiento de la adiccion y/odependencia de los opiáceos, en especial de la dependencia de la heroína. La sustancia activa utilizada a tal efecto es preferentemente la diamorfina y/o unade sus sales obtenidas mediante la adicion de un ácido, farmacéuticamente aceptables. También se describe un procedimiento para el tratamiento de ladependencia de la heroína.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19923551A DE19923551A1 (de) | 1999-05-21 | 1999-05-21 | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
Publications (1)
Publication Number | Publication Date |
---|---|
AR024013A1 true AR024013A1 (es) | 2002-09-04 |
Family
ID=7908879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102385A AR024013A1 (es) | 1999-05-21 | 2000-05-19 | Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceos |
Country Status (25)
Country | Link |
---|---|
US (1) | US20050053647A1 (es) |
EP (1) | EP1183029B1 (es) |
JP (1) | JP4892148B2 (es) |
KR (1) | KR100742471B1 (es) |
CN (1) | CN100457107C (es) |
AR (1) | AR024013A1 (es) |
AT (1) | ATE300301T1 (es) |
AU (1) | AU772139B2 (es) |
BR (1) | BR0011286A (es) |
CA (1) | CA2372339C (es) |
CZ (1) | CZ301230B6 (es) |
DE (2) | DE19923551A1 (es) |
DK (1) | DK1183029T3 (es) |
ES (1) | ES2245311T3 (es) |
HU (1) | HUP0201349A3 (es) |
IL (2) | IL146277A0 (es) |
MX (1) | MXPA01011921A (es) |
NZ (1) | NZ515301A (es) |
PL (1) | PL196741B1 (es) |
PT (1) | PT1183029E (es) |
RU (1) | RU2254130C2 (es) |
TR (1) | TR200103302T2 (es) |
TW (1) | TWI241910B (es) |
WO (1) | WO2000071125A2 (es) |
ZA (1) | ZA200109517B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19960154A1 (de) * | 1999-12-14 | 2001-07-12 | Lohmann Therapie Syst Lts | Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie |
JP4944348B2 (ja) * | 2000-09-08 | 2012-05-30 | 三栄源エフ・エフ・アイ株式会社 | テトラフェニルバクテリオクロリン誘導体およびそれを含む組成物 |
US20030003113A1 (en) * | 2001-06-29 | 2003-01-02 | Lewandowski Leon J. | Individualized addiction cessation therapy |
DE10159745A1 (de) * | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
CA2466536C (en) * | 2001-12-13 | 2012-02-07 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
DE10237057A1 (de) * | 2002-08-09 | 2004-03-25 | Grünenthal GmbH | Opioid-Rezeptor-Antagonisten in Pflasterformulierungen |
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
KR101506925B1 (ko) * | 2004-10-01 | 2015-03-30 | 램스코르 인코포레이티드 | 편리하게 이식가능한 서방형 약물 조성물 |
CA2611831C (en) | 2005-06-17 | 2014-09-16 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
US20070202185A1 (en) * | 2005-12-28 | 2007-08-30 | Kimberly-Clark Worldwide, Inc. | Microencapsulated Delivery Vehicles Having Fugitive Layers |
US20070148448A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Microencapsulated delivery vehicles including cooling agents |
US7442439B2 (en) * | 2005-12-28 | 2008-10-28 | Kimberly-Clark Worldwide, Inc. | Microencapsulated heat delivery vehicles |
US20070148446A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Wipes including microencapsulated delivery vehicles and processes of producing the same |
US7914891B2 (en) * | 2005-12-28 | 2011-03-29 | Kimberly-Clark Worldwide, Inc. | Wipes including microencapsulated delivery vehicles and phase change materials |
US20070145618A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Methods of making microencapsulated delivery vehicles |
US20070145619A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Processes for producing microencapsulated delivery vehicles |
US20070148459A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Microencapsulated delivery vehicles |
US20070149435A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Cleansing composition including microencapsulated delivery vehicles |
US7648046B2 (en) * | 2006-05-30 | 2010-01-19 | Kimberly-Clark Worldwide, Inc. | Dispensing system for dispensing warm wet wipes |
US7497351B2 (en) | 2006-05-30 | 2009-03-03 | Kimberly-Clark Worldwide, Inc. | Wet wipe dispensing system |
US7654412B2 (en) * | 2006-05-30 | 2010-02-02 | Kimberly-Clark Worldwide, Inc. | Wet wipe dispensing system for dispensing warm wet wipes |
EP1889608B1 (en) * | 2006-08-09 | 2012-11-28 | Korea Atomic Energy Research Institute | Therapeutic hydrogel for atopic dermatitis and preparation method thereof |
US8192841B2 (en) * | 2006-12-14 | 2012-06-05 | Kimberly-Clark Worldwide, Inc. | Microencapsulated delivery vehicle having an aqueous core |
WO2008136699A1 (fr) * | 2007-05-04 | 2008-11-13 | Igor Alexandrovich Bazikov | Patch transdermique à microcapsules et procédé de fabrication correspondant |
ES2562878T3 (es) | 2007-05-25 | 2016-03-08 | Indivior Uk Limited | Formulaciones de liberación sostenida de compuestos de risperidona |
US7924142B2 (en) * | 2008-06-30 | 2011-04-12 | Kimberly-Clark Worldwide, Inc. | Patterned self-warming wipe substrates |
EP2531047A4 (en) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | CARRIER WITH AN UNINUTRALIZED TOCOPHERYL PHOSPHATE |
MX2012011355A (es) | 2010-03-30 | 2012-11-30 | Phosphagenics Ltd | Parche de suministro transdermico. |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
CA2881158A1 (en) | 2012-07-26 | 2014-01-30 | Wockhardt Limited | Pharmaceutical composition comprising diamorphine for intranasal administration |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
CA3007587C (en) | 2015-12-09 | 2023-12-05 | Phosphagenics Limited | Pharmaceutical formulation |
JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3760805A (en) * | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3987790A (en) * | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
DE3902013A1 (de) * | 1989-01-25 | 1990-09-20 | Knoll Ag | Pflaster zur transdermalen anwendung |
DE3939376C1 (es) * | 1989-11-29 | 1991-05-08 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De | |
SE9003665D0 (sv) * | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
WO1992013540A1 (fr) * | 1991-02-06 | 1992-08-20 | Guy Parent | Onguent antalgique |
DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
JPH0733681A (ja) * | 1993-05-18 | 1995-02-03 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
DE69429710T2 (de) * | 1993-11-23 | 2002-08-08 | Euro-Celtique S.A., Luxemburg/Luxembourg | Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe |
US5843480A (en) * | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
EP0672416A1 (en) * | 1994-03-14 | 1995-09-20 | Euro-Celtique S.A. | Pharmaceutical composition comprising diamorphine |
JPH08143458A (ja) * | 1994-11-17 | 1996-06-04 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
DE19642043A1 (de) * | 1995-10-23 | 1997-04-24 | Hexal Ag | Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht |
GB9605867D0 (en) * | 1996-03-20 | 1996-05-22 | Svedman Paul | Transdermal device |
DE19654468C1 (de) * | 1996-12-27 | 1998-01-22 | Lohmann Therapie Syst Lts | Extrem flexibles, dermal oder transdermal wirkendes Pflaster und Verfahren zu seiner Herstellung |
US6143278A (en) * | 1998-02-23 | 2000-11-07 | Elkhoury; George F. | Topical application of opioid analgesic drugs such as morphine |
DE19901085C2 (de) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps |
-
1999
- 1999-05-21 DE DE19923551A patent/DE19923551A1/de not_active Withdrawn
-
2000
- 2000-05-17 IL IL14627700A patent/IL146277A0/xx active IP Right Grant
- 2000-05-17 WO PCT/EP2000/004458 patent/WO2000071125A2/de active IP Right Grant
- 2000-05-17 BR BR0011286-0A patent/BR0011286A/pt not_active Application Discontinuation
- 2000-05-17 CZ CZ20014187A patent/CZ301230B6/cs not_active IP Right Cessation
- 2000-05-17 AU AU47577/00A patent/AU772139B2/en not_active Ceased
- 2000-05-17 HU HU0201349A patent/HUP0201349A3/hu unknown
- 2000-05-17 EP EP00929536A patent/EP1183029B1/de not_active Expired - Lifetime
- 2000-05-17 DE DE50010833T patent/DE50010833D1/de not_active Expired - Lifetime
- 2000-05-17 DK DK00929536T patent/DK1183029T3/da active
- 2000-05-17 PT PT00929536T patent/PT1183029E/pt unknown
- 2000-05-17 CA CA002372339A patent/CA2372339C/en not_active Expired - Fee Related
- 2000-05-17 TR TR2001/03302T patent/TR200103302T2/xx unknown
- 2000-05-17 RU RU2001134016/15A patent/RU2254130C2/ru not_active IP Right Cessation
- 2000-05-17 CN CNB008078823A patent/CN100457107C/zh not_active Expired - Fee Related
- 2000-05-17 NZ NZ515301A patent/NZ515301A/xx not_active IP Right Cessation
- 2000-05-17 PL PL351681A patent/PL196741B1/pl not_active IP Right Cessation
- 2000-05-17 JP JP2001505144A patent/JP4892148B2/ja not_active Expired - Fee Related
- 2000-05-17 MX MXPA01011921A patent/MXPA01011921A/es active IP Right Grant
- 2000-05-17 AT AT00929536T patent/ATE300301T1/de active
- 2000-05-17 ES ES00929536T patent/ES2245311T3/es not_active Expired - Lifetime
- 2000-05-17 KR KR1020017014818A patent/KR100742471B1/ko not_active IP Right Cessation
- 2000-05-18 TW TW089109605A patent/TWI241910B/zh not_active IP Right Cessation
- 2000-05-19 AR ARP000102385A patent/AR024013A1/es not_active Application Discontinuation
-
2001
- 2001-11-01 IL IL146277A patent/IL146277A/en not_active IP Right Cessation
- 2001-11-19 ZA ZA200109517A patent/ZA200109517B/en unknown
-
2004
- 2004-09-16 US US10/942,297 patent/US20050053647A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR024013A1 (es) | Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceos | |
DE69830503D1 (de) | Tablette mit verlängerter wirkstoffabgabe zur behandlung der parkinsonkrankheit | |
ATE247115T1 (de) | Substituierte stickstoff-heterocyclische derivate und deren pharmazeutische verwendung | |
ECSP056246A (es) | DERIVADOS DE PIRROLO [3,4-c]PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA | |
PA8748101A1 (es) | Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus | |
ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
BR0211801A (pt) | Derivados de 7h-pirrolo[2,3-d]pirimidina | |
ATE319447T1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
ATE347879T1 (de) | Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung | |
DE60112102D1 (de) | Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen | |
PA8432901A1 (es) | Compuestos de piridilpirrol | |
RU2015102772A (ru) | Бензодиазелипы для мелкоклеточного рака легкого | |
PE20011223A1 (es) | Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico | |
ES2058228T3 (es) | Compuestos activos sobre el sistema cardiovascular. | |
ES2137125B1 (es) | La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal. | |
DE69302829D1 (de) | Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
ATE429435T1 (de) | 7h-pyrrolopyrimidinderivate | |
GEP20247606B (en) | Process for producing pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy | |
GB2000025A (en) | Nitroimidazole formulations | |
EA200300048A1 (ru) | Энантиомер 1,2-аннелированного хиназолина, ингибирующий фарнезилтрансферазу | |
SE9900177D0 (sv) | Vårtmedel | |
BRPI0409790A (pt) | 7-azaindóis e seu uso como terapêuticos | |
MX9302711A (es) | Preparacion de base. | |
ES2031462T3 (es) | Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. | |
WO2018167689A1 (en) | Topical formulation for the treatment of pigmented skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |